
    
      A academic multicentre study whose aims are to study the benefits of a maintenance therapy
      with 24 monthly courses af azacytidine in high-risk MDS patients, previously treated with
      intensive chemotherapy with obtention of a partial or complete response and not eligible for
      allogeneic transplantation
    
  